RESUMO
In this study, a novel pH-sensitive hydrogel beads that is based on gelatin/sodium alginate/chitosan (GEL/SA/CS) loaded with propolis ethanolic extracts (PE) were synthesized. The swelling behavior of GEL/SA/CS hydrogel beads was studied in different pH solutions and compared with unloaded CS (GEL/SA) hydrogel beads. The in vitro release studies have been revealed using four different pH (1.3, 5.0, 6.0, and 6.8), a saliva environment (pH 6.8), a simulated gastric fluid (SGF) (pH 1.3), and a simulated intestinal fluid (SIF) (pH 6.8) to simulate the physiological conditions in gastrointestinal (GI) tract. Propolis-loaded hydrogel beads were found to be stable at pH 1.3, 5.0, 6.0, simulated saliva, SGF, and SIF mediums, whereas the beads lose their stability at pH 6.8 buffer solution. Tested microorganisms displayed greater sensitivity to PE-loaded hydrogel beads compared with pure propolis. Contrary to antimicrobial activity results, antibiofilm activity results of PE-loaded GEL/SA and GEL/SA/CS hydrogel beads were found at low levels. According to the obtained results, the propolis-loaded GEL/SA/CS hydrogel beads synthesized within this study can be used in the treatment of GI tract diseases such as oral mucositis, gastric ulcer, ulcerative colitis, and GI cancer, as controlled releasing carriers of propolis.
Assuntos
Anti-Infecciosos , Bactérias/crescimento & desenvolvimento , Fenômenos Fisiológicos Bacterianos/efeitos dos fármacos , Biofilmes/efeitos dos fármacos , Candida albicans/crescimento & desenvolvimento , Misturas Complexas , Hidrogéis , Própole , Compostos de Alumínio/química , Compostos de Alumínio/farmacocinética , Compostos de Alumínio/farmacologia , Anti-Infecciosos/química , Anti-Infecciosos/farmacocinética , Anti-Infecciosos/farmacologia , Quitosana/química , Quitosana/farmacocinética , Quitosana/farmacologia , Misturas Complexas/química , Misturas Complexas/farmacocinética , Misturas Complexas/farmacologia , Preparações de Ação Retardada/química , Preparações de Ação Retardada/farmacocinética , Preparações de Ação Retardada/farmacologia , Gelatina/química , Gelatina/farmacocinética , Gelatina/farmacologia , Hidrogéis/química , Hidrogéis/farmacocinética , Hidrogéis/farmacologia , Própole/química , Própole/farmacocinética , Própole/farmacologia , Compostos de Sódio/química , Compostos de Sódio/farmacocinética , Compostos de Sódio/farmacologiaRESUMO
The development of chitosan-gelatin (CS-G) hydrogels embedded with ampicillin-loaded hyaluronic acid nanoparticles (HA-NPs) for wound dressing is proposed. It was aimed to provide controlled ampicillin delivery by incorporation of HA-NPs into biocompatible CS-G hydrogel structure. According to in vitro ampicillin release studies, 55% of ampicillin was released from CS-G/HA-NPs hydrogels after 5 days. Antibacterial performance of CS-G/HA-NPs hydrogels was proven with agar disc diffusion test. For cytotoxicity assay, fibroblast cell viability increased in CS-G/HA-NPs hydrogels compared with CS-G group after 24 hr incubation. Consequently, the potential ability of CS-G/HA-NPs hydrogels as a controlled drug delivery system has been verified.
Assuntos
Antibacterianos/farmacologia , Quitosana/farmacocinética , Liberação Controlada de Fármacos/efeitos dos fármacos , Gelatina/farmacocinética , Ácido Hialurônico/farmacocinética , Nanopartículas/metabolismo , Ampicilina/síntese química , Ampicilina/farmacocinética , Animais , Antibacterianos/síntese química , Quitosana/síntese química , Avaliação Pré-Clínica de Medicamentos/métodos , Liberação Controlada de Fármacos/fisiologia , Escherichia coli/efeitos dos fármacos , Escherichia coli/fisiologia , Gelatina/síntese química , Humanos , Ácido Hialurônico/síntese química , Hidrogéis/síntese química , Hidrogéis/farmacocinética , Nanopartículas/química , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/fisiologiaRESUMO
PURPOSE: Besides the tumor cells themselves, solid tumors are comprised of numerous cell types including infiltrating immune cells such as tumor-associated macrophages (TAMs). TAMs are vital stromal components of host immune system and play a critical role in the development of cancer. TAMs can be divided into two subtypes: M1 tumor-suppressive macrophage and M2 tumor-supportive macrophage. To better address the observations of TAMs functional performance, we describe an in vitro system that mimics the populations of TAMs infiltrated into the tumor mass by using our disintegrable supramolecular gelatin (DSG) hydrogels, which are physically crosslinked by host-guest complexations. MATERIALS AND METHODS: The host-guest interaction was adopted between the aromatic groups of gelatin and the photocrosslinkable acrylated ß-cyclodextrins (Ac-ß-CDs) to form the DSG hydrogels. The convenient macrophage/endometrial cancer cells heterospheroid 3D model was set up by DSG hydrogels. RT-PCR and Western blot assays were developed to evaluate the efficiencies of inducers on the macrophages. The ELISA and oxygen saturation assays were performed to measure the secretion of VEGF and consumption of oxygen of tumor and/or macrophages, respectively. To determine the antitumor effects of M2 reprogrammed macrophages in vitro and in vivo, migration assay and tumor xenograft model were used, respectively. RESULTS: The host-guest complexations of DSG hydrogels were controllably broken efficiently by soaking into the solution of competitive guest monomers 1-adamantanamine hydrochloride. The DSG hydrogels help IFN-γ reprogram the M2 to M1 and then decrease the tumor/M2 reprogrammed macrophage cells heterospheroid secretion of VEGF and increase the relative oxygen saturation. Significantly, the co-cultural tumor/M2 reprogrammed group from the disintegrated DSG hydrogels reduced the migration of cancer cells in vitro and the tumor growth in vivo. CONCLUSION: We obtain a TAMs/tumor microenvironment-responsive 3D model based on the novel DSG hydrogels, and will be of utility in cancer therapy and drug discovery.
Assuntos
Neoplasias do Endométrio/patologia , Gelatina/química , Hidrogéis/química , Macrófagos/citologia , Macrófagos/transplante , Animais , Técnicas de Cultura de Células , Neoplasias do Endométrio/terapia , Matriz Extracelular/patologia , Feminino , Gelatina/farmacocinética , Humanos , Hidrogéis/farmacocinética , Camundongos Endogâmicos BALB C , Esferoides Celulares/citologia , Microambiente Tumoral , Ensaios Antitumorais Modelo de XenoenxertoRESUMO
Gelatin molecules have been chemically crosslinked using potentially cytotoxic reagents to prepare stable hydrogels. Hydrophobic interaction is a means of forming physical crosslinks that is a good candidate for enhancing the stability of gelatin hydrogels without using cytotoxic chemicals. In this study, we proposed a new method to fabricate hydrogels from hydrophobically-modified gelatin (HMG) with high content of hydrophobic segments. HMG was first dissolved in dimethyl sulfoxide and poured into a vial with the desired shape. After the solution was freeze-dried, the solid construct was hydrated. The HMG hydrogel containing basic fibroblast growth factor promoted angiogenesis in vivo, indicating that the positively charged hydrophilic growth factor formed an electrostatic complex with negatively charged HMG hydrogel and was gradually released in vivo with the degradation of the hydrogel. In addition, we showed that the hydrophobic segments of HMG enhanced the adsorption of fluorescein sodium, a model for hydrophobic therapeutic agents, to the hydrogel through hydrophobic interaction. Furthermore, in vitro experiments indicated that the hydrophobic agents would be released from the hydrogel in a controlled manner in vivo. These results show that the HMG hydrogel has significant potential as a carrier for both charged hydrophilic drugs and hydrophobic drugs.
Assuntos
Portadores de Fármacos , Fator 2 de Crescimento de Fibroblastos , Fluoresceína , Gelatina , Hidrogéis , Animais , Portadores de Fármacos/química , Portadores de Fármacos/farmacocinética , Portadores de Fármacos/farmacologia , Fator 2 de Crescimento de Fibroblastos/química , Fator 2 de Crescimento de Fibroblastos/farmacocinética , Fator 2 de Crescimento de Fibroblastos/farmacologia , Fluoresceína/química , Fluoresceína/farmacocinética , Fluoresceína/farmacologia , Gelatina/química , Gelatina/farmacocinética , Gelatina/farmacologia , Hidrogéis/química , Hidrogéis/farmacocinética , Hidrogéis/farmacologia , Interações Hidrofóbicas e Hidrofílicas , Masculino , Camundongos , Neovascularização Fisiológica/efeitos dos fármacosRESUMO
The optimal conditions for the preparation of superparamagnetic chitosan plasmid (pReceiver-M29-VEGF165/DH5a) gelatin microspheres (SPCPGMs) were determined. Then, the performance of the SPCPGMs during neovascularization was evaluated in vivo. The SPCPGMs were prepared through a cross-linking curing method and then filled into the hollow scaffold of an artificial bone. Neovascularization at the bone defect position was histologically examined in samples collected 2, 4, 6, and 8 weeks after the operation. The cellular magnetofection rate of superparamagnetic chitosan nanoparticles/plasmid (pReceiver-M29-VEGF165/DH5a) complexes reached 1-3% under static magnetic field (SMF). Meanwhile, the optimal conditions for SPCPGM fabrication were 20% Fe3 O4 (w/v), 4 mg of plasmid, 5.3 mg of glutaraldehyde, and 500 rpm of emulsification rotate speed. Under oscillating magnetic fields (OMFs), 4-6 µg of plasmids was released daily for 21 days. Under the combined application of SMF and OMF, evident neovascularization occurred at the bone defect position 6 weeks after the operation. This result is expected to provide a new type of angiogenesis strategy for the research of bone tissue engineering.
Assuntos
Quitosana , Gelatina , Nanopartículas Magnéticas de Óxido de Ferro/química , Microesferas , Neovascularização Fisiológica , Plasmídeos , Rádio (Anatomia)/irrigação sanguínea , Fator A de Crescimento do Endotélio Vascular , Animais , Quitosana/química , Quitosana/farmacocinética , Quitosana/farmacologia , Gelatina/química , Gelatina/farmacocinética , Gelatina/farmacologia , Técnicas de Transferência de Genes , Neovascularização Fisiológica/efeitos dos fármacos , Neovascularização Fisiológica/genética , Plasmídeos/química , Plasmídeos/genética , Plasmídeos/farmacocinética , Plasmídeos/farmacologia , Coelhos , Rádio (Anatomia)/metabolismo , Fator A de Crescimento do Endotélio Vascular/biossíntese , Fator A de Crescimento do Endotélio Vascular/genéticaRESUMO
The objectives of this work were to prepare a 5 wt% lidocaine-diclofenac ionic liquid drug-loaded gelatin/poly(vinyl alcohol) transdermal patch using a freeze/thaw method and to evaluate its physicochemical properties, in vitro release of lidocaine and diclofenac, and stability test. The lidocaine-diclofenac ionic liquid drug was produced by the ion pair reaction between the hydrochloride salts of lidocaine and the sodium salts of diclofenac. The thermal properties of the final drug product were significantly changed from the primary drugs. The ionic liquid drug could be dissolved in water and mixed in a polymer solution. The resulting transdermal patch was then exposed to 10 cycles of freezing and thawing preparation at - 20°C for 8 h and at 25°C for 4 h, respectively. As a result, it was found that the lidocaine-diclofenac ionic liquid drug-loaded transdermal patch showed good physicochemical properties and could feasibly be used in pharmaceutical applications. The lidocaine-diclofenac ionic liquid drug was not affected by the properties of the transdermal patch due to the lack of chemical interaction between polymer base and drug. The high drug release values of both lidocaine and diclofenac were controlled by the gelatin/poly(vinyl alcohol) transdermal patch. The patch showed good stability over the study period of 3 months when kept at 4°C or under ambient temperature.
Assuntos
Diclofenaco/farmacocinética , Gelatina/farmacocinética , Líquidos Iônicos/farmacocinética , Lidocaína/farmacocinética , Álcool de Polivinil/farmacocinética , Adesivo Transdérmico , Administração Cutânea , Anestésicos Locais/química , Anestésicos Locais/farmacocinética , Anti-Inflamatórios não Esteroides/química , Anti-Inflamatórios não Esteroides/farmacocinética , Preparações de Ação Retardada/química , Preparações de Ação Retardada/farmacocinética , Diclofenaco/química , Combinação de Medicamentos , Liberação Controlada de Fármacos , Congelamento , Gelatina/química , Líquidos Iônicos/química , Lidocaína/química , Álcool de Polivinil/químicaRESUMO
PURPOSE: The aim of this study was to develop a tablet formulation of choline alfoscerate and to assess its bioequivalence by comparing its pharmacokinetic parameters with those of a commercially available soft gelatin capsule (Gliatilin®) in healthy Korean male volunteers. MATERIALS AND METHODS: Film-coated tablet formulation was optimized to control the hygroscopicity of choline alfoscerate. Bioequivalence study was performed under fasted condition with a randomized, single-dose, two-period crossover design. Subjects were orally treated with 1,200 mg of test or reference choline alfoscerate (400 mg × three doses) formulation. Blood samples were collected up to 12 hours the day before dosing to correct the baseline level of choline and 12 hours after dosing to obtain drug absorption profile. Pharmacokinetic parameters were determined after analyzing plasma concentration of choline by using LC-MS/MS. RESULTS: Hygroscopicity of choline alfoscerate was successfully controlled by adding suitable amount of Neusilin® (magnesium aluminometasilicate) in the film-coated tablet. Stability of the tablet formulation was also confirmed under the accelerated condition for 3 months. Bioequivalence study showed that the mean area under the plasma concentration-time curve from time 0 to infinity of test tablet and reference soft capsule was 3.428±2.170 and 3.305±1.803 µgâ h/mL, respectively; the mean Cmax was 0.365±0.158 and 0.380±0.108 µg/mL, respectively; and the mean Tmax was 3.51±2.57 and 3.85±3.19 hours, respectively. The 90% CIs for geometric mean ratios of test to reference formulation for AUC0-t and Cmax were 84.51%-111.98% and 83.31%-104.10%, respectively, and satisfied the EMA regulatory criteria for bioequivalence. CONCLUSION: Pharmacokinetic parameters including the Cmax and AUC0-t determined after oral administration of the two formulations in healthy Korean male volunteers showed that the differences between the formulations (tablet vs soft capsule) were not significant for bioequivalence. Both formulations were well tolerated, with no serious adverse events reported.
Assuntos
Gelatina/farmacocinética , Glicerilfosforilcolina/farmacocinética , Voluntários Saudáveis , Adulto , Cápsulas , Cromatografia Líquida de Alta Pressão , Estudos Cross-Over , Gelatina/administração & dosagem , Gelatina/sangue , Glicerilfosforilcolina/administração & dosagem , Glicerilfosforilcolina/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Conformação Molecular , República da Coreia , Comprimidos , Equivalência Terapêutica , Adulto JovemRESUMO
Continuous delivery of growth factors to the injury site is crucial to creating a favorable microenvironment for cartilage injury repair. In the present study, we fabricated a novel sustained-release scaffold, stromal-derived factor-1α (SDF-1α)/transforming growth factor-ß1 (TGF-ß1)-loaded silk fibroin-porous gelatin scaffold (GSTS). GSTS persistently releases SDF-1α and TGF-ß1, which enhance cartilage repair by facilitating cell homing and chondrogenic differentiation. Scanning electron microscopy showed that GSTS is a porous microstructure and the protein release assay demonstrated the sustainable release of SDF-1α and TGF-ß1 from GSTS. Bone marrow-derived mesenchymal stem cells (MSCs) maintain high in vitro cell activity and excellent cell distribution and phenotype after seeding into GSTS. Furthermore, MSCs acquired enhanced chondrogenic differentiation capability in the TGF-ß1-loaded scaffolds (GSTS or GST: loading TGF-ß1 only) and the conditioned medium from SDF-1α-loaded scaffolds (GSTS or GSS: loading SDF-1α only) effectively promoted MSCs migration. GSTS was transplanted into the osteochondral defects in the knee joint of rats, and it could promote cartilage regeneration and repair the cartilage defects at 12 weeks after transplantation. Our study shows that GSTS can facilitate in vitro MSCs homing, migration, chondrogenic differentiation and SDF-1α and TGF-ß1 have a synergistic effect on the promotion of in vivo cartilage forming. This SDF-1α and TGF-ß1 releasing GSTS have promising therapeutic potential in cartilage repair.
Assuntos
Cartilagem , Quimiocina CXCL12 , Condrogênese/efeitos dos fármacos , Fibroínas , Gelatina , Fator de Crescimento Transformador beta1 , Animais , Cartilagem/lesões , Cartilagem/metabolismo , Cartilagem/patologia , Diferenciação Celular/efeitos dos fármacos , Movimento Celular/efeitos dos fármacos , Quimiocina CXCL12/química , Quimiocina CXCL12/farmacocinética , Quimiocina CXCL12/farmacologia , Preparações de Ação Retardada/química , Preparações de Ação Retardada/farmacocinética , Preparações de Ação Retardada/farmacologia , Fibroínas/química , Fibroínas/farmacocinética , Fibroínas/farmacologia , Gelatina/química , Gelatina/farmacocinética , Gelatina/farmacologia , Masculino , Porosidade , Ratos , Fator de Crescimento Transformador beta1/química , Fator de Crescimento Transformador beta1/farmacocinética , Fator de Crescimento Transformador beta1/farmacologiaRESUMO
Continuous drug administration with better adherence to treatment and less invasive procedures is important in treating retinal diseases such as age-related macular disease. In this study, we report a drug-refillable device consisting of a silicone reservoir and an injectable gelatin/chitosan gel (iGel). The silicone reservoir was fabricated with polydimethylsiloxane (PDMS) using a computer-aided design and manufacturing to have micropores at a releasing side for uniaxial release to the sclera. A stainless steel wire and sheet were combined in the side and bottom of the reservoir to ensure flexibility and to fit on the curvature of the eyeball and prevent irritation to the sclera through the bottom of the reservoir. The drug was injected and formulated in the reservoir by in situ crosslinking of gelatin/chitosan gel with the crosslinker; 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride. The in vitro release study using fluorescein molecules showed that the release rate from encapsulated iGel in the reservoir was slower than that from the original iGel. After reinjecting the iGel into the reservoir, the same release profile as the first injection was observed. The reservoir containing iGel was placed on the sclera of a rabbit and the distribution of 150â¯kDa fluorescein isothiocyanate-dextran (FD150) in the retina and choroid/retinal pigment epithelium (choroid/RPE) was studied. The cryosections showed that FD150 was observed in the choroid/RPE. Homogenates of the retina and choroid/RPE showed fluorescence during 12â¯weeks implantation, indicating the drug could be delivered to the retina by using the device. The drug filling was successful into the reservoir implanted on the sclera through the conjunctiva by using a needle. In conclusion, the refillable drug delivery device is a promising tool to administer drugs long-term by reinjection with less invasiveness to intraocular tissues.
Assuntos
Quitosana/farmacocinética , Sistemas de Liberação de Medicamentos/instrumentação , Desenho de Equipamento , Gelatina/farmacocinética , Retina/metabolismo , Esclera/metabolismo , Animais , Quitosana/administração & dosagem , Preparações de Ação Retardada/administração & dosagem , Preparações de Ação Retardada/farmacocinética , Dimetilpolisiloxanos/química , Sistemas de Liberação de Medicamentos/métodos , Desenho de Equipamento/métodos , Gelatina/administração & dosagem , Masculino , Nylons/química , Coelhos , Retina/efeitos dos fármacos , Esclera/efeitos dos fármacos , Silicones/químicaRESUMO
A large amount of food-grade animal by-products is annually produced during industrial processing and they are normally utilized as animal feed or other low-value purposes. These by-products are good sources of valuable proteins, including collagen or gelatin. The revalorization of collagen may lead to development of a high benefit-to-cost ratio. In this review, the major approaches for generation of collagen peptides with a wide variety of bioactivities were summarized, including antihypertensive, antioxidant and antidiabetic activities, and beneficial effects on bone, joint and skin health. The biological potentials of collagen peptides and their bioavailability were reviewed. Moreover, the unique advantages of collagen peptides over other therapeutic peptides were highlighted. In addition, the current challenges for development of collagen peptides as functional food ingredients were also discussed. This article discusses the opportunity to utilize collagen peptides as high value-added bio-functional ingredients in the food industry.
Assuntos
Colágeno/química , Peptídeos/química , Animais , Anti-Hipertensivos/análise , Anti-Hipertensivos/farmacocinética , Antioxidantes/análise , Antioxidantes/farmacocinética , Disponibilidade Biológica , Produtos Biológicos/análise , Produtos Biológicos/farmacocinética , Colágeno/farmacocinética , Gelatina/química , Gelatina/farmacocinética , Humanos , Hipoglicemiantes/análise , Hipoglicemiantes/farmacocinética , Peptídeos/farmacocinéticaRESUMO
The mucosal immune system is the host's first line of defense against invasion by foreign pathogens. Gelatin nanoparticles (GNPs) are suitable carriers for the delivery of antigens via various routes of administration. In the present study, GNPs were modified with polyethyleneimine (PEI), a positively charged polymer. Then, ovalbumin (OVA) and polyinosinic:polycytidylic acid (poly(I:C)), an immunostimulant, were adsorbed onto the surface of the positively charged GNPs. We assessed whether GNPs could act as an effective mucosal vaccine that is capable of inducing both mucosal and systemic immune responses. The results showed that GNPs effectively adsorbed OVA/poly(I:C), facilitated cellular uptake by RAW 264.7 macrophage cells and murine bone marrow-derived dendritic cells (BMDCs) in vitro, and led to increased expression of the maturation markers CD80 and CD86 on BMDCs. Furthermore, GNPs induced increased secretion of proinflammatory cytokines in both RAW 264.7 and BMDCs. C57BL/6 mice that were intranasally twice-immunized with OVA/poly(I:C)-loaded GNPs produced high levels of serum OVA-specific IgG antibodies and secretory IgA in nasal and lung lavage. Spleen cells from immunized mice were collected and re-stimulated with OVA, and results showed significantly augmented production of IFN-γ, IL-4, IL-5, and IL-6 in mice that received OVA/poly(I:C)-loaded GNPs. Moreover, intranasal immunization with OVA/poly(I:C)-loaded GNPs resulted in the inhibition of EG7 tumor growth in C57BL/6 mice. Taken together, these results indicate that nasal administration of OVA/poly(I:C)-loaded GNPs elicited effective mucosal and systemic immune responses, which might be useful for further applications of antigen delivery. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 1228-1237, 2019.
Assuntos
Adjuvantes Imunológicos , Antígenos , Portadores de Fármacos , Gelatina , Imunidade nas Mucosas/efeitos dos fármacos , Imunização , Nanopartículas/química , Poli I-C , Polietilenoimina , Adjuvantes Imunológicos/química , Adjuvantes Imunológicos/farmacocinética , Adjuvantes Imunológicos/farmacologia , Administração Intranasal , Animais , Antígenos/química , Antígenos/farmacologia , Células da Medula Óssea/imunologia , Citocinas/imunologia , Células Dendríticas/imunologia , Portadores de Fármacos/química , Portadores de Fármacos/farmacocinética , Portadores de Fármacos/farmacologia , Feminino , Gelatina/química , Gelatina/farmacocinética , Gelatina/farmacologia , Camundongos , Absorção Nasal/efeitos dos fármacos , Absorção Nasal/imunologia , Poli I-C/química , Poli I-C/farmacocinética , Poli I-C/farmacologia , Polietilenoimina/química , Polietilenoimina/farmacocinética , Polietilenoimina/farmacologia , Células RAW 264.7RESUMO
The number of cases of erectile dysfunction (ED) caused after radical prostatectomy (RP) prostate cancer treatment is increasing steadily. Although various studies have been conducted for treatment of post-RP ED, there is still a need for more effective methods. A dual growth factor incorporated heparin-pluronic/gelatin-poly(ethylene glycol)-tyramine (HP/GPT) hydrogel, which consists of a basic fibroblast growth factor (bFGF)-loaded HP hydrogel and nerve growth factor (NGF)-loaded GPT hydrogel, can control dose and rate of growth factor release. In this study, we demonstrated that dual growth factor incorporated HP/GPT hydrogel could further improve erectile function in a rat model of bilateral cavernous nerve injury (BCNI). We showed that erectile function was decreased after BCNI, but it was further improved by treatment with a dual growth factor incorporated HP/GPT hydrogel compared with groups treated with single growth factor in a rat model of cavernous nerve injury. Also, we observed an increase in cyclic guanosine monophosphate (cGMP) levels in the dual growth factor group when compared with the groups treated with single growth factor. This effect was associated with greater upregulation of nitric oxide synthase and endothelial nitric oxide synthase expression in the penile tissue of the group treated with dual growth factor incorporated HP/GPT than in the other experimental groups. Apoptosis in the penile tissue treated with the dual growth factor incorporated HP/GPT hydrogel was lower than those treated singly with either bFGF or NGF incorporated GPT hydrogel. Both α-smooth muscle actin and CD31 expression increased in the group treated with dual growth factor incorporated HP/GPT hydrogel when compared to in the other experimental groups. Altogether, our results proved that the sequential and continuous release of growth factors from dual growth factor incorporated HP/GPT hydrogel prevented fibrosis and nerve damage induced by BCNI in the corpus cavernosum, and promoted the recovery of erectile function. Dual growth factor incorporated HP/GPT hydrogel may be a potent clinical application for the treatment of post-RP ED and could potentially be used various biomedical application in tissue regnerative medicine.
Assuntos
Disfunção Erétil/tratamento farmacológico , Fator 2 de Crescimento de Fibroblastos , Fator de Crescimento Neural , Traumatismos dos Nervos Periféricos/tratamento farmacológico , Animais , Preparações de Ação Retardada/química , Preparações de Ação Retardada/farmacocinética , Preparações de Ação Retardada/farmacologia , Disfunção Erétil/metabolismo , Disfunção Erétil/fisiopatologia , Fator 2 de Crescimento de Fibroblastos/química , Fator 2 de Crescimento de Fibroblastos/farmacocinética , Fator 2 de Crescimento de Fibroblastos/farmacologia , Gelatina/química , Gelatina/farmacocinética , Gelatina/farmacologia , Heparina/química , Heparina/farmacocinética , Heparina/farmacologia , Masculino , Fator de Crescimento Neural/química , Fator de Crescimento Neural/farmacocinética , Fator de Crescimento Neural/farmacologia , Traumatismos dos Nervos Periféricos/metabolismo , Traumatismos dos Nervos Periféricos/fisiopatologia , Poloxâmero/química , Poloxâmero/farmacocinética , Poloxâmero/farmacologia , Ratos , Ratos Sprague-Dawley , Tiramina/química , Tiramina/farmacocinética , Tiramina/farmacologiaRESUMO
In this study, central composite design was utilized for the preparation and optimization of chitosan-gelatin hydrogel films containing metformin using different concentrations of genipin as crosslinking agent. Solvent evaporation technique was used to develop hydrogel films. The formulated hydrogels were subjected to study the drug release in the simulated gastric pH1.2 for 3h. Initial burst release was observed from hydrogel during the first 2h of dissolution in gastric simulated environment. Different polymer ratios in formulation showed significant influence on T50% and dynamic swelling of hydrogel. The highest T50% was observed at 40.23min and dynamic swelling at 9.1. It was observed that by changing the polymer ratio with cross-linker, release rate of metformin could be modified. Cross-linker also affects the release rate as its concentration increases, the release rate decreases. The physical state of hydrogel was investigated by scanning electron microscope. It indicated the uniform presence of drug crystals in hydrogel matrix system. Fourier transform infrared spectroscopy (FTIR) confirmed the presence of hydrogen and ionic bonds between polymers and crosslinking agent leaving the drug intact in the matrix system. Scanning electron microscopy (SEM) images confirmed the uniform drug distribution. As per conclusion, the immediate release, pH sensitive, hydrogel formulation with good safety profile can be successfully fabricated by using CHI and GLN polymers with varying concentration of crosslinking agent.
Assuntos
Quitosana , Gelatina , Iridoides , Metformina , Administração Oral , Animais , Quitosana/química , Quitosana/farmacocinética , Quitosana/farmacologia , Preparações de Ação Retardada/química , Preparações de Ação Retardada/farmacocinética , Preparações de Ação Retardada/farmacologia , Gelatina/química , Gelatina/farmacocinética , Gelatina/farmacologia , Concentração de Íons de Hidrogênio , Iridoides/química , Iridoides/farmacocinética , Iridoides/farmacologia , Masculino , Metformina/química , Metformina/farmacocinética , Metformina/farmacologia , CoelhosRESUMO
Rapid clearance and low ocular bioavailability are drawbacks of conventional ophthalmic eye drops. To increase the ocular drug resistance time and improve efficacy, an in situ forming and thermosensitive chitosan-gelatin hydrogel was developed. The feasibility of using this hydrogel as a topical eye drop formulation for sustained release of timolol maleate was evaluated. The flexible hydrogel that was co-crosslinked with ßglycerophosphate disodium salt hydrate (ß-GD) and genipin showed a fast gel formation at 37⯰C. The swelling properties and in vitro biodegradation characteristics showed a strong relationship with the initial genipin concentration. In vitro release profiles demonstrated that crosslinking with genipin reduced the release rate of entrapped model drugs and timolol maleate. In vitro cytotoxicity tests showed that the hydrogel was non-toxic to Chinese hamster fibroblast V79 cells. The hydrogel was further applied as eye drop formulations for sustained release of timolol maleate to reduce intraocular pressure (IOP). A fast gel formation was observed after instilling the chitosan-gelatin solution into the lower conjunctival sac of the rabbit eyes, and the in situ formed hydrogels protected the drugs from clearance by tears, and released the drugs in a sustained manner. Furthermore, administration of timolol maleate containing chitosan-gelatin hydrogels showed a long-lasting and effective IOP lowering efficacy for up to 24â¯h compared with the conventional eye drops. These results suggested that ß-GD and genipin co-crosslinked chitosan-gelatin hydrogels could be a useful ocular drug delivery platform with enhanced therapeutic effects and reduced side effects.
Assuntos
Quitosana , Sistemas de Liberação de Medicamentos/métodos , Gelatina , Hidrogéis , Teste de Materiais , Timolol , Animais , Linhagem Celular , Quitosana/química , Quitosana/farmacocinética , Quitosana/farmacologia , Cricetulus , Gelatina/química , Gelatina/farmacocinética , Gelatina/farmacologia , Hidrogéis/química , Hidrogéis/farmacocinética , Hidrogéis/farmacologia , Injeções Intraoculares , Masculino , Coelhos , Timolol/química , Timolol/farmacocinética , Timolol/farmacologiaRESUMO
Bacterial infection is a major problem world-wide, especially in wound treatment where it can severely prolong the healing process. In this study, a double drug co-delivery elastic antibacterial nanocomposite was developed by combining ciprofloxacin (CPX) and polymyxin B sulfate-loaded halloysite clay nanotubes (HNTs-B) into a gelatin elastomer. CPX nanoparticles which act against both gram positive and gram-negative bacterium were dispersed directly in the matrix, and polymyxin B sulfate was loaded in HNTs and then distributed into the matrix. The effect of CPX and HNTs-B content on the physical properties, cytotoxicity, fibroblast adhesion and proliferation, in vitro drug release behavior and anti-bacterial properties were systematically investigated. The ciprofloxacin crystals and HNT-B were distributed in the matrix uniformly. The HNTs in the drug loading system not only enhanced the matrix' tensile strength but also slowed down the release rate of the high dissoluble polymyxin B sulfate. When the amount of HNT in the matrix increased, the thermal stability and tensile strength also increased but the polymyxin B sulfate release rate decreased because the HNTs prevented the drug release inside. All the nanocomposites exhibited antimicrobial activity against both gram-negative and gram-positive bacteria with the dual combination of drugs released from the nanocomposites. Furthermore, this kind of gelatin-based nanocomposites possesses higher water-absorbing quality, low cytotoxicity, adaptable biodegradability and good elasticity which can satisfy the requirements for an ideal biomaterial for use in wound healing applications.
Assuntos
Anti-Infecciosos , Bandagens , Ciprofloxacina , Sistemas de Liberação de Medicamentos/métodos , Polimixina B , Pseudomonas aeruginosa/crescimento & desenvolvimento , Staphylococcus aureus/crescimento & desenvolvimento , Silicatos de Alumínio/química , Silicatos de Alumínio/farmacocinética , Silicatos de Alumínio/farmacologia , Animais , Anti-Infecciosos/química , Anti-Infecciosos/farmacocinética , Anti-Infecciosos/farmacologia , Linhagem Celular , Ciprofloxacina/química , Ciprofloxacina/farmacocinética , Ciprofloxacina/farmacologia , Argila , Elastômeros/farmacocinética , Elastômeros/farmacologia , Gelatina/química , Gelatina/farmacocinética , Gelatina/farmacologia , Membranas Artificiais , Camundongos , Nanocompostos/química , Nanocompostos/uso terapêutico , Nanotubos/química , Polimixina B/química , Polimixina B/farmacocinética , Polimixina B/farmacologiaRESUMO
The aim of the present study was to develop a novel pH sensitive gelatin methacrylate hydrogel for the controlled delivery of Gentamicin (GS) and Ampicillin (Amp). GS and Amp having synergistic activity is effective in killing multi drug resistant bacteria. The hydrogel was well characterized using FTIR, XRD and SEM techniques. The drug loading and encapsulation efficiency were found to be 85.0 and 77.0% for GS, 79.0 and 88.0% for Amp, respectively. The in vitro swelling, degradation and release profiles suggest the pH dependent behaviour of hydrogel. DPPH Assay confirmed the role of 2-amino guanidine in nullifying the side effect of GS and inhibition percentage of DDLHG is found to be 85.0%. Antimicrobial studies revealed the increased efficiency of the drug combination in killing bacteria.
Assuntos
Ampicilina , Antibacterianos , Escherichia coli/crescimento & desenvolvimento , Gelatina , Gentamicinas , Hidrogéis , Metacrilatos , Staphylococcus aureus/crescimento & desenvolvimento , Ampicilina/química , Ampicilina/farmacocinética , Ampicilina/farmacologia , Animais , Antibacterianos/química , Antibacterianos/farmacocinética , Antibacterianos/farmacologia , Linhagem Celular , Preparações de Ação Retardada/química , Preparações de Ação Retardada/farmacocinética , Preparações de Ação Retardada/farmacologia , Gelatina/química , Gelatina/farmacocinética , Gelatina/farmacologia , Gentamicinas/química , Gentamicinas/farmacocinética , Gentamicinas/farmacologia , Hidrogéis/química , Hidrogéis/farmacocinética , Hidrogéis/farmacologia , Concentração de Íons de Hidrogênio , Metacrilatos/química , Metacrilatos/farmacocinética , Metacrilatos/farmacologia , CamundongosRESUMO
A new conceptual nanoparticle consisting of a silica-coated iron oxide magnetic core and a fattigation-based biocompatible shell with oleic acid and hydrophilic protein (gelatin). The prepared particle can be a useful theranostics platform material for diagnostic imaging and as a drug delivery system. Oleic acid and gelatin were conjugated on the silica-coated magnetic nanoparticle surface to provide three primary functionalities: 1) enhancing biocompatibility and solubility in aqueous solution and providing the ability to incorporate hydrophobic chemical drugs into the shell for delivery, 2) improving treatment-response magnetic monitoring as a diagnostic agent with low nanotoxicity, and 3) increasing anticancer efficacy owing to the controlled release of the incorporated drug in cells and in an animal model. We prepared magnetic-silica nanoparticles with super-paramagnetic properties, which are utilized as a T2-weighted magnetic resonance imaging agent. After formation of an oleic acid-gelatin shell, the prepared materials exhibited high loading capacity for a hydrophobic anticancer drug (paclitaxel). Our particle platform system exhibited higher therapeutic efficacy and lower toxicological effects in vitro and in an in vivo cancer model than a clinically available chemo-drug (Taxol®). Our findings strongly suggest that this nanoparticle system can serve as a platform for cancer therapy by the incorporation of chemical drugs.
Assuntos
Materiais Revestidos Biocompatíveis , Nanopartículas de Magnetita/química , Melanoma/tratamento farmacológico , Neoplasias Experimentais/tratamento farmacológico , Paclitaxel , Nanomedicina Teranóstica/métodos , Animais , Linhagem Celular Tumoral , Materiais Revestidos Biocompatíveis/química , Materiais Revestidos Biocompatíveis/farmacocinética , Materiais Revestidos Biocompatíveis/farmacologia , Gelatina/química , Gelatina/farmacocinética , Gelatina/farmacologia , Melanoma/metabolismo , Melanoma/patologia , Camundongos , Neoplasias Experimentais/metabolismo , Neoplasias Experimentais/patologia , Ácido Oleico/química , Ácido Oleico/farmacocinética , Ácido Oleico/farmacologia , Paclitaxel/química , Paclitaxel/farmacocinética , Paclitaxel/farmacologia , Dióxido de Silício/química , Dióxido de Silício/farmacocinética , Dióxido de Silício/farmacologiaRESUMO
Microspheres can be regarded as a suitable platform for the development of ad hoc drug delivery systems, since the targeted release of a therapeutic agent can effectively contribute to support and improve a pharmacological protocol. However, several crucial factors related to the selection of materials, drugs and fabrication techniques should be critically analyzed in order to enhance the expected performance. Dealing with highly compatible materials, e.g. naturally-derived polymers and "green" reagents, can be a valid approach. For this aim, gelatin, chitosan and blend microspheres were produced by emulsion technique simply using distilled water and olive oil. Necessarily, due to the intrinsic instability of the selected materials in aqueous environment, microspheres were cross-linked with genipin, an extremely low cytotoxic agent, at three different concentration (i.e., 0.1, 0.5, 1% w/v). Collected microspheres were then loaded with methylene blue (MB), as drug model. Morphological analysis revealed homogeneous microspheres characterized by an average diameter comprised in the range 42-54µm. In vitro MB temporal delivery was assessed until complete release, which occurred in about 3days for gelatin and 30days for chitosan microspheres. Nanoindentation analysis was performed to evaluate how polymers and genipin influenced the mechanical properties of microspheres. Finally, the effect of released MB was investigated by means of chicken embryo chorioallantoic membrane assay, highlighting anti-angiogenic properties for gelatin differently from chitosan and blend microspheres.
Assuntos
Quitosana , Sistemas de Liberação de Medicamentos/métodos , Gelatina , Iridoides , Microesferas , Animais , Embrião de Galinha , Galinhas , Quitosana/química , Quitosana/farmacocinética , Quitosana/farmacologia , Gelatina/química , Gelatina/farmacocinética , Gelatina/farmacologia , Iridoides/química , Iridoides/farmacocinética , Iridoides/farmacologia , Azul de Metileno/química , Azul de Metileno/farmacocinética , Azul de Metileno/farmacologiaRESUMO
PURPOSE: To develop and characterize a ferrous-methylthymol blue-gelatin gel dosimeter with low optical background and appropriate additives for reduced rate of auto-oxidation and diffusion. METHODS: A mixed-level multifactorial design of experiments was used to test the effects of the concentrations of sulfuric acid, 5-nitro-1,10-phenanthroline (Nn), and glyoxal (Gx) on the background absorbance, dose sensitivity, and auto-oxidation of the tested gel dosimeter. The dosimetric properties of the proposed ferrous-methylthymol blue-gelatin dosimeter, doped with Nn and Gx, were compared with the undoped formulation and with ferrous-xylenol orange-gelatin gel dosimeters. Irradiations were performed in both small-scale cuvette samples and large 400-mL bulk samples. In addition to that, a new kinetic model for the signal development postirradiation was derived based on chemical principles and used for comparison of the different formulations. RESULTS: The new formulation showed a reduced auto-oxidation rate, while maintaining low background absorbance relative to the common ferrous-xylenol orange-gelatin gel dosimeter. Compared with undoped ferrous-xylenol orange or ferrous-methylthymol blue gels, the dose sensitivity of the new formulation is approximately 2 to 3 times lower, but remains clinically adequate. A previously unreported dose rate dependence of the dose sensitivity was observed, and a new kinetic model for the signal development postirradiation was used to investigate this effect. Similar dose rate dependences in gels containing either methylthymol blue or xylenol orange, with or without doping with Nn and Gx, were observed, suggesting that the low ferrous ammonium sulfate concentrations used in studied formulations were responsible for this effect. CONCLUSIONS: A multifactorial design of experiments and a new kinetic model for the signal development postirradiation were successfully employed to optimize the composition and characterize the properties of a new ferrous-methylthymol blue-gelatin gel dosimeter doped with 5-nitro-1,10-phenanthroline and glyoxal. Concrete recommendations were provided for precise dosimetry using the new formulation.
Assuntos
Azul de Bromotimol/análogos & derivados , Dosímetros de Radiação , Azul de Bromotimol/farmacocinética , Gelatina/farmacocinética , Géis , Cinética , RadiometriaRESUMO
The liquid and semisolid matrix technology, filling liquids, semi-solids and gels in hard gelatin capsule are promising, thus, there is a need of enhanced research interest in the technology. Therefore, the present study was aimed to investigate isoniazid (freely soluble) and metronidazole (slightly soluble) gels filled in hard gelatin capsules for the effect of poloxamers of different viscosities on release of the drugs. Gel of each drug (10% w/w, particle size 180-250 µm), prepared by mixing poloxamer and 8% w/w hydrophilic silicon dioxide (Aerosil® A200), was assessed for rheology, dispersion stability and release profile. Both the drugs remained dispersed in majority of gels for more than 30 days, and dispersions were depended on gels' viscosity, which was further depended on viscosity of poloxamers. A small change in viscosity was noted in gels on storage. FTIR spectra indicated no interactions between components of the gels. The gels exhibited thixotropic and shear-thinning behaviour, which were suitable for filling in hard gelatin capsules without any leakage from the capsules. The release of both drugs from the phase-stable gels for 30 days followed first-order kinetics and was found to be correlated to drugs' solubility, poloxamers' viscosity, polyoxyethylene contents and proportion of block copolymer (poloxamers) in the gels. The findings of the present study indicated that release of drugs of different solubilities (isoniazid and metronidazole) might be modified from gels using different poloxamers and Aerosil® A200.